摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(3-噻吩基)噻吩-2-羧酸 | 60141-31-3

中文名称
5-(3-噻吩基)噻吩-2-羧酸
中文别名
——
英文名称
[2,3'-bithiophene]-5-carboxylic acid
英文别名
5-Carboxy-2,3'-dithienyl;5-(3-thienyl)-2-thiophenecarboxylic acid;[2,3']bithiophenyl-5-carboxylic acid;5-(3-Thienyl)thiophene-2-carboxylic acid;5-thiophen-3-ylthiophene-2-carboxylic acid
5-(3-噻吩基)噻吩-2-羧酸化学式
CAS
60141-31-3
化学式
C9H6O2S2
mdl
——
分子量
210.277
InChiKey
NUZWQKDXTFZYAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    188-190°
  • 沸点:
    364.9±32.0 °C(Predicted)
  • 密度:
    1.438±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    93.8
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2934999090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-(3-噻吩基)噻吩-2-羧酸 、 S-(isobutyl)cysteinylsulfone-glycine-nitrile methanesulfonate 在 4-二甲氨基吡啶盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺N,N-二异丙基乙胺 作用下, 以 四氢呋喃 为溶剂, 反应 25.17h, 以28%的产率得到(+/-)-N-[5-(3-thienyl)thiophene-2-carbonyl]-S-(isobutyl)cysteinylsulfone-glycine-nitrile
    参考文献:
    名称:
    Selective Nitrile Inhibitors To Modulate the Proteolytic Synergism of Cathepsins S and F
    摘要:
    A series of dipeptide nitriles with different P3 substituents was designed to explore the S3 binding pocket of cathepsin S. Racemic 7-16 and the enantiopure derivative (R)-22 proved to be potent inhibitors of human cathepsin S and exhibited notable selectivity over human cathepsins L, K, and B. Inhibition of cathepsin F, the functional synergist of cathepsin S, was not observed. The azadipeptide analogue of 22, compound 26, was highly potent but nonselective.
    DOI:
    10.1021/jm300734k
  • 作为产物:
    描述:
    参考文献:
    名称:
    Selective Nitrile Inhibitors To Modulate the Proteolytic Synergism of Cathepsins S and F
    摘要:
    A series of dipeptide nitriles with different P3 substituents was designed to explore the S3 binding pocket of cathepsin S. Racemic 7-16 and the enantiopure derivative (R)-22 proved to be potent inhibitors of human cathepsin S and exhibited notable selectivity over human cathepsins L, K, and B. Inhibition of cathepsin F, the functional synergist of cathepsin S, was not observed. The azadipeptide analogue of 22, compound 26, was highly potent but nonselective.
    DOI:
    10.1021/jm300734k
点击查看最新优质反应信息

文献信息

  • Redox-Neutral Photocatalytic C−H Carboxylation of Arenes and Styrenes with CO2
    作者:Matthias Schmalzbauer、Thomas D. Svejstrup、Florian Fricke、Peter Brandt、Magnus J. Johansson、Giulia Bergonzini、Burkhard König
    DOI:10.1016/j.chempr.2020.08.022
    日期:2020.10
    Carbon dioxide (CO2) is an attractive one-carbon (C1) building block in terms of sustainability and abundance. However, its low reactivity limits applications in organic synthesis as typically high-energy reagents are required to drive transformations. Here, we present a redox-neutral C─H carboxylation of arenes and styrenes using a photocatalytic approach. Upon blue-light excitation, the anthrolate
    就可持续性和丰富性而言,二氧化碳(CO 2)是有吸引力的一碳(C1)构建基块。但是,其低反应性限制了有机合成中的应用,因为通常需要高能试剂来驱动转化。在这里,我们介绍了使用光催化方法的芳烃和苯乙烯的氧化还原中性CH羧基化。在蓝光激发下,邻苯二甲酸根阴离子光催化剂能够将许多芳族化合物还原为相应的自由基阴离子,这些自由基阴离子会与CO 2反应得到羧酸。高通量筛选和计算分析表明,底物的电子亲和力和亲核性之间的正确平衡至关重要。这种新颖的方法使许多芳族化合物能够羧基化,包括许多经典的羧化化学中不容忍的化合物。超过50个使用CO 2或酮进行C-H官能化的例子说明了广泛的适用性。该方法为常见的芳烃的增值提供了新的机会,并可能在后期的CH羧基化中得到应用。
  • Synthesis and Antimicrobial Evaluation of Nitazoxanide-Based Analogues: Identification of Selective and Broad Spectrum Activity
    作者:T. Eric Ballard、Xia Wang、Igor Olekhnovich、Taylor Koerner、Craig Seymour、Joseph Salamoun、Michelle Warthan、Paul S. Hoffman、Timothy L. Macdonald
    DOI:10.1002/cmdc.201000475
    日期:2011.2.7
    library composed of nitazoxanide‐based analogues was synthesized and assayed for increased antibacterial efficacy against the pyruvate–ferredoxin oxidoreductase (PFOR) using microorganisms Helicobacter pylori, Campylobacter jejuni and Clostridium difficile. Derivatives were found to recapitulate and improve activity against these organisms and select analogues were tested for their ability to disrupt
    合成了一个由基于硝唑尼特的类似物组成的文库,并使用微生物幽门螺杆菌、空肠弯曲杆菌和艰难梭菌对丙酮酸-铁氧还蛋白氧化还原酶 (PFOR) 的抗菌功效进行了分析。发现衍生物可以概括并提高针对这些生物的活性,并测试了选择的类似物直接破坏 PFOR 酶的能力。该文库还针对葡萄球菌的活性进行了筛选,并鉴定出能够以低微摩尔最低抑制浓度抑制葡萄球菌和所有 PFOR 生物体的类似物,并且对人类包皮细胞的毒性较低。
  • N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
    申请人:——
    公开号:US20040171881A1
    公开(公告)日:2004-09-02
    Disclosed are compounds of the formula 1 wherein the variables R N , R C , R 1 , R 25 , R 2 , and R 3 are as defined herein. These compounds have activity as inhibitors of beta-secretase and are therefore useful in treating a variety of discorders such as Alzheimer's Disease.
    本文披露了式1的化合物,其中变量RN、RC、R1、R25、R2和R3的定义如本文所述。这些化合物具有抑制β-分泌酶的活性,因此可用于治疗多种疾病,如阿尔茨海默病。
  • NOVEL MCH RECEPTOR ANTAGONISTS
    申请人:Beck James Peter
    公开号:US20090170913A1
    公开(公告)日:2009-07-02
    The present invention relates to a melanin concentrating hormone antagonist compound of formula (I); wherein Ar 1 , L 1 , R 1 , q, X, R 2 , R 3 , R 4 , and R 5 are as defined, or a pharmaceutically acceptable salt, solvate, or enantiomer thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    本发明涉及一种公式(I)的黑色素浓集激素拮抗剂化合物;其中Ar1,L1,R1,q,X,R2,R3,R4和R5如定义,或其药学上可接受的盐,溶剂合物或对映体,用于治疗,预防或改善与肥胖和相关疾病相关的症状。
  • POPOLITOVA E. A.; LIPKIN A. E., XIM.-FARMATSEVT. ZH. <KNFZ-AN>, 1976, 10, HO 1, 75-77
    作者:POPOLITOVA E. A.、 LIPKIN A. E.
    DOI:——
    日期:——
查看更多

同类化合物

试剂2,2'-Thieno[3,2-b]thiophene-2,5-diylbis-3-thiophenecarboxylicacid 苯并[b]噻吩,3-(2-噻嗯基)- 甲基[2,3'-联噻吩]-5-羧酸甲酯 牛蒡子醇 B 十四氟-Alpha-六噻吩 三丁基(5''-己基-[2,2':5',2''-三联噻吩]-5-基)锡 α-四联噻吩 α-六噻吩 α-五联噻吩 α-七噻吩 α,ω-二己基四噻吩 5,5′-双(3-己基-2-噻吩基)-2,2′-联噻吩 α,ω-二己基六联噻吩 Α-八噻吩 alpha-三联噻吩甲醇 alpha-三联噻吩 [3,3-Bi噻吩]-2,2-二羧醛 [2,2’]-双噻吩-5,5‘-二甲醛 [2,2':5',2''-三联噻吩]-5,5''-二基双[三甲基硅烷] [2,2'-联噻吩]-5-甲醇,5'-(1-丙炔-1-基)- [2,2'-联噻吩]-5-甲酸甲酯 [2,2'-联噻吩]-5-乙酸,a-羟基-5'-(1-炔丙基)-(9CI) C-[2,2-二硫代苯-5-基甲基]胺 5’-己基-2,2’-联噻吩-5-硼酸频哪醇酯 5-辛基-1,3-二(噻吩-2-基)-4H-噻吩并[3,4-c]吡咯-4,6(5H)-二酮 5-苯基-2,2'-联噻吩 5-溴5'-辛基-2,2'-联噻吩 5-溴-5′-己基-2,2′-联噻吩 5-溴-5'-甲酰基-2,2':5'2'-三噻吩 5-溴-3,3'-二己基-2,2'-联噻吩 5-溴-3'-癸基-2,2':5',2''-三联噻吩 5-溴-2,2-双噻吩 5-溴-2,2'-联噻吩-5'-甲醛 5-氯-5'-苯基-2,2'-联噻吩 5-氯-2,2'-联噻吩 5-正辛基-2,2'-并噻吩 5-己基-5'-乙烯基-2,2'-联噻吩 5-己基-2,2-二噻吩 5-全氟己基-5'-溴-2,2'-二噻吩 5-全氟己基-2,2′-联噻吩 5-乙酰基-2,2-噻吩基 5-乙氧基-2,2'-联噻吩 5-丙酰基-2,2-二噻吩 5-{[[2,2'-联噻吩]-5-基}噻吩-2-腈 5-[5-(5-己基噻吩-2-基)噻吩-2-基]噻吩-2-羧酸 5-(羟甲基)-[2,2]-联噻吩 5-(噻吩-2-基)噻吩-2-甲腈 5-(5-甲酰基-3-己基噻吩-2-基)-4-己基噻吩-2-甲醛 5-(5-甲基噻吩-2-基)噻吩-2-甲醛 5-(5-噻吩-2-基噻吩-2-基)噻吩-2-羧酸 5-(5-乙炔基噻吩-2-基)噻吩-2-甲醛